Explore the latest strategic trends, research and analysis
Bolstered by much-needed vaccine news, businesses still face many questions. Planning for a range of scenarios can help leaders prepare in uncertain times.
UNICEF will work with over 350 airlines and freight companies to deliver nearly 2 billion COVID-19 vaccines to developing countries next year.
AstraZeneca's vaccine for COVID-19 could be around 90% effective without any serious side effects. The vaccine can also be refrigerated, rather than frozen.
Here are 3 questions organizations involved in producing and distributing COVID-19 vaccines should be asking themselves to protect against cyberattack.
Moderna's new vaccine uses messenger RNA (mRNA) technology, which relies on synthetic genes that can be generated and manufactured in weeks.
Google has added COVID-19 related information to its travel system Google Travel. Hosts can add information like cleaning procedures and contact-free check-in.
The COVID-19 pandemic is exacerbating the global burden of neglected tropical diseases (NTDs). Here are three strategies that can help reverse this trend.
The new Pfizer COVID-19 vaccine that was found to be 90% effective will need to be refrigerated at -70 to -80 degrees, otherwise it will spoil in five days.
Pfizer says its experimental COVID-19 vaccine is over 90% effective, raising global hopes of ending the pandemic. But what are the obstacles to a vaccine reaching the world’s poorest?
A team of researchers have discovered a way to potentially increase the effectiveness of a coronavirus vaccine, by mimicking the disease's structure.
The latest World Economic forum/Ipsos survey on vaccine confidence shows that on average, across 15 countries, vaccination intent is down by 4 points since August.
Refrigeration is essential for vaccine distribution, but in rural Africa, electricity can be sporadic and non-existent. Solar-powered fridges can help.
Around the world, 360 million people are living with viral hepatitis. We have the tools and knowhow to eliminate this disease – so what's stopping us?
As the coronavirus pandemic continues, health expert Anatole Manzi warns that countries must take action to ensure the continuity of essential healthcare services.
The study by Arizona University has shown that high-quality antibodies are still being produced five to seven months after SARS-CoV-2 infection.